Cargando…

Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study

BACKGROUND: After a hip fracture, a catabolic state develops, with increased bone loss during the first year. The aim of this study was to evaluate the effects of postoperative treatment with calcium, vitamin D, and bisphosphonates (alone or together) with nutritional supplementation on total hip an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flodin, Lena, Sääf, Maria, Cederholm, Tommy, Al-Ani, Amer N, Ackermann, Paul W, Samnegård, Eva, Dalen, Nils, Hedström, Margareta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094579/ https://www.ncbi.nlm.nih.gov/pubmed/25045257 http://dx.doi.org/10.2147/CIA.S63987

Ejemplares similares

Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study
por: Flodin, Lena, et al.
Publicado: (2015)

Increased 1-year survival and discharge to independent living in overweight hip fracture patients
por: Flodin, Lena, et al.
Publicado: (2016)

Sex effects on short-term complications after hip fracture: a prospective cohort study
por: Ekström, Wilhelmina, et al.
Publicado: (2015)

Normal gastric emptying time of a carbohydrate-rich drink in elderly patients with acute hip fracture: a pilot study
por: Hellström, Per M., et al.
Publicado: (2017)

Secondary fracture prevention with osteoporosis medication after a fragility fracture in Sweden remains low despite new guidelines
por: Ek, Stina, et al.
Publicado: (2023)

Hospital Length of Stay After Hip Fracture and It’s Association With 4-Month Mortality—Exploring the Role of Patient Characteristics
por: Ek, Stina, et al.
Publicado: (2021)

Internal fixation or hip replacement for undisplaced femoral neck fractures? Pre-fracture health differences reflect survival and functional outcome
por: EK, Stina, et al.
Publicado: (2022)

Calcium intake in elderly patients with hip fractures
por: Cho, Karl, et al.
Publicado: (2008)

Risk factors for osteoporosis are common in young and middle-aged patients with femoral neck fractures regardless of trauma mechanism
por: Al-Ani, Amer N, et al.
Publicado: (2013)

Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate‐Treated Patients in a Real‐World Setting
por: Banefelt, Jonas, et al.
Publicado: (2021)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Wearable Neuromuscular Electrical Stimulation on Quadriceps Muscle Can Increase Venous Flow
por: Flodin, Johanna, et al.
Publicado: (2023)

Prosthesis or osteosynthesis for the treatment of a pathological hip fracture? A nationwide registry-based cohort study
por: Tsagkozis, Panagiotis, et al.
Publicado: (2021)

Good clinical outcome for the majority of younger patients with hip fractures: a Swedish nationwide study on 905 patients younger than 50 years of age
por: Thoors, Oscar, et al.
Publicado: (2021)

Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients
por: Misof, B.M., et al.
Publicado: (2017)

The obesity paradox and mortality after pathological hip fractures: a Swedish registry study
por: EHNE, Jessica, et al.
Publicado: (2022)

Changes of and interrelationships between performance-based function and gait and patient-reported function 1 year after total hip arthroplasty
por: Naili, Josefine E., et al.
Publicado: (2019)

Waiting more than 24 hours for hip fracture surgery is associated with increased risk of adverse outcomes for sicker patients: a nationwide cohort study of 63,998 patients using the Swedish Hip Fracture Register
por: GREVE, Katarina, et al.
Publicado: (2023)

Comorbidity and the association with 1-year mortality in hip fracture patients: can the ASA score and the Charlson Comorbidity Index be used interchangeably?
por: Ek, Stina, et al.
Publicado: (2021)

Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
por: Brun, Lucas R, et al.
Publicado: (2014)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
por: Ronsley, Rebecca, et al.
Publicado: (2020)

The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men
por: Franzon, Kristin, et al.
Publicado: (2019)

Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
por: Fisher, Alex, et al.
Publicado: (2010)

Bisphosphonates Prescription for Patients With Hip Fractures Based on Evaluation by a Dentist
por: Inoue, Hayato, et al.
Publicado: (2023)

Effects of electrode size and placement on comfort and efficiency during low-intensity neuromuscular electrical stimulation of quadriceps, hamstrings and gluteal muscles
por: Flodin, J., et al.
Publicado: (2022)

Knee extensor force production and discomfort during neuromuscular electrical stimulation of quadriceps with and without gluteal muscle co-stimulation
por: Flodin, J., et al.
Publicado: (2022)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

No association between waiting time to surgery and mortality for healthier patients with hip fracture: a nationwide Swedish cohort of 59,675 patients
por: Greve, Katarina, et al.
Publicado: (2020)

To withhold or to implement bisphosphonate after cementless hip arthroplasty: a dilemma in elderly hip fracture patients
por: Lee, Young-Kyun, et al.
Publicado: (2019)

Trends in Hip Fracture Incidence, Recurrence, and Survival by Education and Comorbidity: A Swedish Register-based Study
por: Meyer, Anna C., et al.
Publicado: (2021)

Bisphosphonate-Induced Periprosthetic Fracture: A Cause of Painful Total Hip Arthroplasty
por: Bhattacharyya, Rahul, et al.
Publicado: (2014)

Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women
por: Izano, Monika A., et al.
Publicado: (2020)

Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
por: Kamimura, Mikio, et al.
Publicado: (2019)

Functional performance, nutritional status, and body composition in ambulant community-dwelling individuals 1–3 years after suffering from a cerebral infarction or intracerebral bleeding
por: Vahlberg, Birgit, et al.
Publicado: (2016)

The Sernbo score as a predictor of 1-year mortality after hip fracture: a registry study on 55,716 patients
por: Mellner, Carl, et al.
Publicado: (2020)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates
por: Heckman, George A, et al.
Publicado: (2002)

Comparison of the efficacy of three once-weekly bisphosphonates on bone mineral density gains in Korean women
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
por: Arends, Suzanne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v5lr1unrm3keqmhiubqpk06jgj